What is the current Fish-Oil Based Drugs market size?

The Fish-Oil Based Drugs market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Fish-Oil Based Drugs market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Fish-Oil Based Drugs market?

Key drivers include rising awareness of omega-3 benefits and growing applications in pharmaceuticals.

What are the major challenges facing the Fish-Oil Based Drugs market?

Challenges include fluctuating raw material prices and stringent regulatory requirements.

Which regions are leading the Fish-Oil Based Drugs market?

North America and Europe are currently the leading regions, driven by high demand.

Who are the top companies in the Fish-Oil Based Drugs market?

Top companies include pharmaceutical giants and specialty omega-3 manufacturers.

What future opportunities exist in the Fish-Oil Based Drugs market?

Emerging opportunities include growing demand from Asia-Pacific and increasing use in nutraceuticals.

How is technology impacting the Fish-Oil Based Drugs market?

Advances in purification technology are improving product quality and yields.

What is the current regulatory landscape for Fish-Oil Based Drugs?

The regulatory landscape is complex, with varying standards across regions and countries.

What is the future outlook for the Fish-Oil Based Drugs market?

The future outlook is positive, with growing demand and increasing applications.

Fish-Oil Based Drugs Market Intelligence Report 2026 — Updated June 2026

Fish-Oil Based Drugs by Application (Coronary Heart Disease (CHD), Rheumatoid Arthritis, Stroke, Raynaud's Syndrome, Dysmenorrhea, Other), by Types (Mackerel, Tuna, Herring, Salmon, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 4, 2025Updated: Jun 8, 2026

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Fish-Oil Based Drugs Market Overview

The Fish-Oil Based Drugs market is defined as the industry involved in the development, production, and distribution of pharmaceutical products derived from fish oil, which are used to treat various health conditions. The relevance of this market lies in its growing demand due to the increasing awareness of the health benefits of omega-3 fatty acids found in fish oil. As the Fish-Oil Based Drugs market size is expected to reach $1.4 billion by 2026, the growth outlook and market forecast indicate a promising future for this industry, driven by its industry expansion into new therapeutic areas, such as cardiovascular and neurological disorders. The scope of this market encompasses various synonyms, including omega-3 based pharmaceuticals and fish oil-derived drugs.

Loading chart…

The current Fish-Oil Based Drugs market size is approximately $1.1 billion, with a growth forecast of 8% CAGR during the forecast period of 2026-2033. The market is driven by macro drivers such as the increasing prevalence of chronic diseases, the growing demand for preventive care, and the expanding applications of fish oil-based drugs. Key forces shaping the industry include technology shifts towards more efficient production methods, regulations supporting the development of new therapeutic areas, and consumer behavior favoring natural and sustainable products. The largest region in this market is North America, while the fastest-growing region is Asia-Pacific, driven by the increasing adoption of fish oil-based drugs in countries such as China and India.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.25 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Solutex GC; Aker Biomarine; Croda International PLC; Stepan Company; Pharma Marine; GC Rieber Oil; Clover Corporation; BASF SE; Cellana; Omega Protein Corporation; United Laboratories
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Fish-Oil Based Drugs market is poised for significant growth, driven by increasing awareness of the health benefits associated with omega-3 fatty acids. Understanding the dynamics of this market is crucial for stakeholders seeking to capitalize on emerging trends and opportunities.

Growth Drivers2 items

The growing prevalence of cardiovascular diseases and the subsequent demand for preventive treatments are driving the Fish-Oil Based Drugs market size, with a projected growth forecast that underscores the potential for expansion into new therapeutic areas.

Advancements in drug formulation technologies have improved the bioavailability and efficacy of fish-oil based drugs, making them more attractive to patients and healthcare providers, thus fueling market growth.

Restraints2 items

Stringent regulatory requirements and the high cost of clinical trials can hinder the development and approval of new fish-oil based drugs, potentially limiting the Fish-Oil Based Drugs market size and growth forecast.

The availability of alternative treatments and supplements may also restrain market growth, as consumers opt for over-the-counter products rather than prescription drugs, affecting the overall dynamics of the Fish-Oil Based Drugs market.

Opportunities2 items

The increasing adoption of fish-oil based drugs in emerging economies presents a significant opportunity for market expansion, driven by growing healthcare expenditure and an escalating demand for innovative treatments.

Research into the therapeutic potential of fish-oil based drugs beyond cardiovascular diseases, such as in neurological disorders and inflammation, could further enhance the Fish-Oil Based Drugs market size and growth forecast.

Challenges2 items

Ensuring the sustainability and quality of fish oil sources is a critical challenge facing the Fish-Oil Based Drugs market, as environmental concerns and fishing regulations impact the availability of raw materials.

Differentiating products in a crowded market and demonstrating superior efficacy and safety profiles are key challenges for manufacturers seeking to establish a strong presence in the Fish-Oil Based Drugs market and capitalize on the growth forecast.

Market Segmentation

Loading chart…

The Application segment in the Fish-Oil Based Drugs market refers to the various uses of fish oil-based drugs in different therapeutic areas. This segmentation category contributes significantly to the overall Fish-Oil Based Drugs market size, as it helps to identify the specific areas where these drugs are most effective. The Fish-Oil Based Drugs segmentation by application includes subtypes such as cardiovascular health, neurological disorders, and inflammatory diseases, among others. Understanding these subtypes is crucial in determining the market size and growth potential of fish oil-based drugs in each application area.

The Types segment in the Fish-Oil Based Drugs market encompasses the different forms of fish oil-based drugs available, including prescription and over-the-counter (OTC) medications. This segmentation category is vital in assessing the market taxonomy of fish oil-based drugs, as it helps to distinguish between various product types and their corresponding market shares. The subtypes under this category include prescription drugs and OTC drugs, each with its own set of characteristics and market dynamics. Analyzing these subtypes is essential in evaluating the overall Fish-Oil Based Drugs market size and growth prospects.

Fish-Oil Based Drugs Segmentation Breakdown13 items

Application

Coronary Heart Disease (CHD)

Rheumatoid Arthritis

Stroke

Raynaud's Syndrome

Dysmenorrhea

Other

Types

Mackerel

Tuna

Herring

Salmon

Others

Regional Insights

Loading chart…

The Fish-Oil Based Drugs market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 35% of the market share, and the fastest-growing region, driven by increasing adoption of fish-oil based drugs and investments in healthcare infrastructure. Key drivers for Asia Pacific include rising demographics with growing elderly populations, increasing policies supporting healthcare development, and a mature ecosystem with established pharmaceutical companies.

In North America, key drivers include high adoption rates of fish-oil based drugs, favorable policies and investments in research and development, and a well-established infrastructure for pharmaceutical manufacturing and distribution. Europe is driven by a strong ecosystem with a high concentration of pharmaceutical companies, increasing demographics with growing demand for healthcare services, and supportive policies for healthcare development. Latin America and Middle East & Africa are driven by growing demographics, increasing adoption of fish-oil based drugs, and investments in healthcare infrastructure, although they account for smaller shares of the market.

The regional forecast indicates that the Fish-Oil Based Drugs market will continue to grow, driven by increasing demand for preventive care and investments in healthcare infrastructure. Understanding the key drivers and trends in each region is crucial for companies to develop effective strategies and capitalize on the Fish-Oil Based Drugs market growth opportunities.

Competitive Landscape

The Fish-Oil Based Drugs market is moderately consolidated, with a mix of global players and local/regional companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Fish-Oil Based Drugs competitive landscape is characterized by high competition, with companies focusing on differentiation through premium pricing, innovative products, and strong channel partnerships. Global players are expanding their presence in emerging markets, while local companies are focusing on regional expansion and localization.

Companies in the Fish-Oil Based Drugs market are adopting various strategies to stay competitive, including M&A, partnerships, product launches, and R&D investments. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. Key players are focusing on innovation pipelines, local manufacturing, and OEM tie-ups to stay ahead in the market. The following companies are notable for their strategic focus:

Solutex GC: regional expansion

Aker Biomarine: innovation pipeline

Croda International PLC: premium pricing

Stepan Company: vertical integration

Pharma Marine: local manufacturing

GC Rieber Oil: OEM tie-ups

Key Fish-Oil Based Drugs Companies11 items

Solutex GC

Aker Biomarine

Croda International PLC

Stepan Company

Pharma Marine

GC Rieber Oil

Clover Corporation

BASF SE

Cellana

Omega Protein Corporation

United Laboratories

Market Ecosystem

The Fish-Oil Based Drugs ecosystem encompasses a complex network of stakeholders, spanning upstream raw material suppliers to downstream end users. This ecosystem can be broadly categorized into three main segments: upstream, midstream, and downstream. Upstream participants include technology providers and raw material suppliers, while midstream involves integrators and manufacturers. Downstream encompasses channels, distributors, and end users, where value is ultimately created and captured through the delivery of fish-oil based drugs to patients.

Raw material suppliers — provide fish oil extracts

Technology providers — develop formulation technologies

OEMs / manufacturers — produce fish-oil based drugs

Distributors / channel partners — manage logistics and supply chains

Regulators/standards bodies — oversee approvals and compliance

Service providers / after-sales — offer support and maintenance services

End users / buyers — prescribe and administer fish-oil based drugs

In the Fish-Oil Based Drugs ecosystem, value flows through the interactions and interdependencies among these participants. Control points, such as regulatory approvals and supply chain management, influence the adoption and availability of fish-oil based drugs. Dependency risks, including input constraints and standards compliance, can impact the stability of the ecosystem. Furthermore, switching costs, partnerships, and interoperability requirements can affect the flexibility and responsiveness of the ecosystem. A thorough value chain analysis is essential to understanding these dynamics and identifying opportunities for growth and improvement in the Fish-Oil Based Drugs ecosystem.

Recent Industry Insights

The Fish-Oil Based Drugs industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between pharmaceutical companies and research institutions have led to the discovery of new formulations and applications of fish-oil based drugs. Notably, there have been several mergers & acquisitions that have reshaped the competitive landscape of the industry. Furthermore, companies have launched new products and technologies, expanding their portfolios and catering to the growing demand for fish-oil based drugs. Regulatory changes have also played a crucial role in shaping the industry, with authorities implementing new guidelines and standards for the production and distribution of these drugs.

In addition to these developments, there has been a noticeable shift in consumer trends, with an increasing preference for natural and sustainable products. This has driven companies to invest in research and development, as well as funding rounds or expansions to enhance their capabilities and capacities. As the industry continues to evolve, it is likely that we will see more innovative products and technologies emerge, further driving growth and adoption of fish-oil based drugs.

Analyst Overview

As the Lead Analyst for this study, my expert view on the Fish-Oil Based Drugs market outlook is that it presents a moderately attractive opportunity, driven by growing demand for omega-3 fatty acid-based treatments. The competitive intensity is relatively high, with several established players and new entrants vying for market share. In the long term, I anticipate a stable growth trajectory, fueled by increasing awareness of the health benefits of fish-oil based products. The innovation landscape is characterized by ongoing research into new formulations and delivery methods, which will help maintain a stable demand–supply balance. However, key risk factors include fluctuations in raw material prices and regulatory changes. Overall, the Fish-Oil Based Drugs market is poised for steady growth, with opportunities for differentiation through innovative products and strategic partnerships.

12 items

1. Executive Summary

2. Fish-Oil Based Drugs Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Fish-Oil Based Drugs Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Fish-Oil Based Drugs Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Fish-Oil Based Drugs Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Fish-Oil Based Drugs Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Fish-Oil Based Drugs Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Fish-Oil Based Drugs Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Fish-Oil Based Drugs Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Fish-Oil Based Drugs Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Fish-Oil Based Drugs Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Fish-Oil Based Drugs Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Fish-Oil Based Drugs Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Fish-Oil Based Drugs Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Fish-Oil Based Drugs Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Fish-Oil Based Drugs Market Competition by Key Manufacturers

9.1. Global Fish-Oil Based Drugs Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Fish-Oil Based Drugs: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Solutex GC

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Aker Biomarine

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Croda International PLC

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Stepan Company

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Pharma Marine

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. GC Rieber Oil

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Clover Corporation

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. BASF SE

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Cellana

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Omega Protein Corporation

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. United Laboratories

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Fish-Oil Based Drugs Market

Figure 4: Global Fish-Oil Based Drugs Market: Drivers

Figure 5: Global Fish-Oil Based Drugs Market: Challenges

Figure 6: Global Fish-Oil Based Drugs Market: Trends

Figure 7: Global Fish-Oil Based Drugs Market: Opportunity

Figure 8: Global Fish-Oil Based Drugs Market: Restraint

Figure 9: Global Fish-Oil Based Drugs Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Fish-Oil Based Drugs Market Value (USD Million) By Region

Figure 19: Global Fish-Oil Based Drugs Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Fish-Oil Based Drugs Market Value (USD Million) By Region

Figure 27: Global Fish-Oil Based Drugs Market Share (%) By: Regions (2032)

Figure 28: Global Fish-Oil Based Drugs Market Volume (K) By Region

Figure 29: Global Fish-Oil Based Drugs Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Fish-Oil Based Drugs Market Value (USD Million) By Region

Figure 37: Global Fish-Oil Based Drugs Market Share (%) By: Regions (2032)

Figure 38: Global Fish-Oil Based Drugs Market Volume (K) By Region

Figure 39: Global Fish-Oil Based Drugs Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

117 items

Table 1: Market Segmentation Analysis

Table 2: Global Fish-Oil Based Drugs Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Fish-Oil Based Drugs Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Fish-Oil Based Drugs Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Fish-Oil Based Drugs Market Value (USD Million) By Region

Table 14: Global Fish-Oil Based Drugs Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Fish-Oil Based Drugs Market Volume (K) By Region

Table 31: Global Fish-Oil Based Drugs Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Fish-Oil Based Drugs Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Fish-Oil Based Drugs Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Fish-Oil Based Drugs Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Solutex GC Basic Information And Sales Area

Table 52: Solutex GC. Products Portfolio

Table 53: Aker Biomarine Basic Information And Sales Area

Table 54: Aker Biomarine. Products Portfolio

Table 55: Croda International PLC Basic Information And Sales Area

Table 56: Croda International PLC. Products Portfolio

Table 57: Stepan Company Basic Information And Sales Area

Table 58: Stepan Company. Products Portfolio

Table 59: Pharma Marine Basic Information And Sales Area

Table 60: Pharma Marine. Products Portfolio

Table 61: GC Rieber Oil Basic Information And Sales Area

Table 62: GC Rieber Oil. Products Portfolio

Table 63: Clover Corporation Basic Information And Sales Area

Table 64: Clover Corporation. Products Portfolio

Table 65: BASF SE Basic Information And Sales Area

Table 66: BASF SE. Products Portfolio

Table 67: Cellana Basic Information And Sales Area

Table 68: Cellana. Products Portfolio

Table 69: Omega Protein Corporation Basic Information And Sales Area

Table 70: Omega Protein Corporation. Products Portfolio

Table 71: United Laboratories Basic Information And Sales Area

Table 72: United Laboratories. Products Portfolio

Table 73: Global Market Value (USD Million) (2025-2032) By Application

Table 74: Global Market Share (%) By Application (2032)

Table 75: Global Market Value (USD Million) (2025-2032) By Types

Table 76: Global Market Share (%) By Types (2032)

Table 77: Global Market Volume (K) (2025-2032) By Application

Table 78: Global Market Share (%) By Application (2032)

Table 79: Global Market Volume (K) (2025-2032) By Types

Table 80: Global Market Share (%) By Types (2032)

Table 81: Global Fish-Oil Based Drugs Market Value (USD Million) By Region

Table 82: Global Fish-Oil Based Drugs Market Share (%) By Region (2025-2032)

Table 83: North America Market Value (USD Million) (2025-2032) By Country

Table 84: North America Market Value (USD Million) (2025-2032) By Application

Table 85: North America Market Value (USD Million) (2025-2032) By Types

Table 86: Europe Market Value (USD Million) (2025-2032) By Country

Table 87: Europe Market Value (USD Million) (2025-2032) By Application

Table 88: Europe Market Value (USD Million) (2025-2032) By Types

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 90: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 91: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 92: South America Market Value (USD Million) (2025-2032) By Country

Table 93: South America Market Value (USD Million) (2025-2032) By Application

Table 94: South America Market Value (USD Million) (2025-2032) By Types

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 96: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 97: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 98: Global Fish-Oil Based Drugs Market Volume (K) By Region

Table 99: Global Fish-Oil Based Drugs Market Share (%) By Region (2025-2032)

Table 100: North America Market Volume (K) (2025-2032) By Country

Table 101: North America Market Volume (K) (2025-2032) By Application

Table 102: North America Market Volume (K) (2025-2032) By Types

Table 103: Europe Market Volume (K) (2025-2032) By Country

Table 104: Europe Market Volume (K) (2025-2032) By Application

Table 105: Europe Market Volume (K) (2025-2032) By Types

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 107: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 108: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 109: South America Market Volume (K) (2025-2032) By Country

Table 110: South America Market Volume (K) (2025-2032) By Application

Table 111: South America Market Volume (K) (2025-2032) By Types

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 113: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 114: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 115: Research Programs/Design For This Report

Table 116: Key Data Information From Secondary Sources

Table 117: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Fish-Oil Based Drugs Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.25 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Solutex GC; Aker Biomarine; Croda International PLC; Stepan Company; Pharma Marine; GC Rieber Oil; Clover Corporation; BASF SE; Cellana; Omega Protein Corporation; United Laboratories
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Fish-Oil Based Drugs Segmentation Breakdown13 items

Application

Coronary Heart Disease (CHD)

Rheumatoid Arthritis

Stroke

Raynaud's Syndrome

Dysmenorrhea

Other

Types

Mackerel

Tuna

Herring

Salmon

Others

Regional Insights

Loading chart…

Competitive Landscape

Solutex GC: regional expansion

Aker Biomarine: innovation pipeline

Croda International PLC: premium pricing

Stepan Company: vertical integration

Pharma Marine: local manufacturing

GC Rieber Oil: OEM tie-ups

Key Fish-Oil Based Drugs Companies11 items

Solutex GC

Aker Biomarine

Croda International PLC

Stepan Company

Pharma Marine

GC Rieber Oil

Clover Corporation

BASF SE

Cellana

Omega Protein Corporation

United Laboratories

Market Ecosystem

Raw material suppliers — provide fish oil extracts

Technology providers — develop formulation technologies

OEMs / manufacturers — produce fish-oil based drugs

Distributors / channel partners — manage logistics and supply chains

Regulators/standards bodies — oversee approvals and compliance

Service providers / after-sales — offer support and maintenance services

End users / buyers — prescribe and administer fish-oil based drugs

Recent Industry Insights

Analyst Overview

Table of Contents